Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease—Possible Causes and Future Considerations
Charalambos Michaeloudes, Stephanos Christodoulides, Panayiota Christodoulou, Theodora-Christina Kyriakou, Ioannis Patrikios, Anastasis Stephanou · 2023
Read Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease—Possible Causes and Future Considerations by Charalambos Michaeloudes, Stephanos Christodoulides, Panayiota Christodoulou, Theodora-Christina Kyriakou, Ioannis Patrikios, Anastasis Stephanou (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10675410.txt.
Description
Charalambos Michaeloudes and co-authors review why fish oil compounds help some heart patients and not others, in a 2023 paper. The two compounds, known as EPA and DHA, come from omega-3 fats and can lower blood fats and calm vessel inflammation. Yet large trials of these supplements have given conflicting results, which confuses the public and clinicians.
The review traces how the two compounds act in shared and unlike ways inside cells. They swap into cell membranes in place of more inflammatory fats, steer gene switches, and leave marks on DNA control. Trial design flaws may explain part of the clash in results. The authors propose better trial and lab design, better supplement mixes, and markers that predict who will respond, so treatment can be matched to the person.
Catalog record
| CREATOR | Charalambos Michaeloudes, Stephanos Christodoulides, Panayiota Christodoulou, Theodora-Christina Kyriakou, Ioannis Patrikios, Anastasis Stephanou |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |